ReiThera is an Italian CDMO dedicated to process development and GMP manufacturing of viral vectors for genetic vaccines and advanced therapy medicinal products (ATMPs). They have extensive expertise in developing scalable processes for Adeno-Associated Vectors (AAV), Lentivirus, Adenoviral vectors (AdV), Modified Vaccinia Ankara, and Herpes Simplex Vectors. Their state-of-the-art facility in Rome features stirred-tank bioreactors at 50L, 200L, 1000L, and 2000L scales, fixed-bed bioreactors, a filling suite, and quality control laboratories. They also develop their own vaccine candidates (e.g., GRAd-COV2).
viral vector process development and GMP manufacturing, AAV vectors, lentivirus production, adenoviral vectors, Modified Vaccinia Ankara, Herpes Simplex vectors, scalable viral vector manufacturing from 50L to 2000L
1 site worldwide
Involvement in 2 clinical trials
No reviews available yet.
No documents available.